SCHEMBL4907500

SCHEMBL4907500

CCN(c1nc(-c2ccc(C(C)(C)C)cc2)sc1C)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.39
MAPT P10636 3/20 0.38
HCRTR2 O43614 1/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HDAC3 O15379 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC11 Q96DB2 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
NR1H4 Q96RI1 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
RARG P13631 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901379 0.92 KDM4E (0.41) TRPM8MAPTLMNAALDH1A1HDAC8
SCHEMBL4903647 0.91 ALDH1A1 (0.39) TRPM8MAPTLMNAALDH1A1HPGD
SCHEMBL4895175 0.90 MAPT (0.36) TRPM8MAPTHCRTR2LMNAALDH1A1
SCHEMBL4907195 0.90 LMNA (0.39) TRPM8MAPTHCRTR2LMNAALDH1A1
SCHEMBL4903806 0.90 LMNA (0.42) TRPM8LMNAALDH1A1HPGDALOX15
SCHEMBL4904359 0.89 KDM4E (0.40) TRPM8MAPTLMNAALDH1A1HPGD
SCHEMBL4906619 0.89 LMNA (0.40) TRPM8MAPTLMNAALDH1A1HPGD
SCHEMBL4906402 0.87 LMNA (0.39) TRPM8MAPTHCRTR2LMNAALDH1A1
SCHEMBL4906218 0.86 TRPM8 (0.45) TRPM8
SCHEMBL4903777 0.85 LMNA (0.39) TRPM8LMNAALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TRPM8 4317/4885MAPT 1786/4885HCRTR2 3933/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TRPM8 4317/4885MAPT 1786/4885HCRTR2 3933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.